Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-ranging study of oral albaconazole for distal subungual onychomycosis
2008-002418-23Phase 2Completed
- Sponsor
- Stiefel Laboratories
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of albaconazole in onychomycosis (5 arms), sponsored by Stiefel Laboratories. Primary endpoint: Effective treatment at week 52. Started Nov 2008; status: completed.
02
Drugs
albaconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2008-002418-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002418-23.